Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds
Yuchen Nan, Yan‐Jin Zhang
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Fran Robson, Khadija Shahed Khan, Thi Khanh Le, et al.
Molecular Cell (2020) Vol. 79, Iss. 5, pp. 710-727
Open Access | Times Cited: 391
A 20-year historical review of West Nile virus since its initial emergence in North America: Has West Nile virus become a neglected tropical disease?
Shannon E. Ronca, Jeanne C. Ruff, Kristy O. Murray
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 5, pp. e0009190-e0009190
Open Access | Times Cited: 112
Current State of Human Gene Therapy: Approved Products and Vectors
Aladdin Y. Shchaslyvyi, Svitlana Antonenko, Maksym G. Tesliuk, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1416-1416
Open Access | Times Cited: 51
RNA therapeutics in the clinic
Alexander M. Curreri, Disha Sankholkar, Samir Mitragotri, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases
Atiyabanu N. Saiyed, Abhay R. Vasavada, Kaid Johar
Future Journal of Pharmaceutical Sciences (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 50
A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future
Emily Holz, Martine Darwish, Devin B. Tesar, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 600-600
Open Access | Times Cited: 29
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics
Sai Pallavi Pradeep, Shipra Malik, Frank J. Slack, et al.
RNA (2023) Vol. 29, Iss. 4, pp. 434-445
Open Access | Times Cited: 22
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 13
Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence
Zoltán Bereczki, Bettina Benczik, Olivér M. Balogh, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 9
Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci
Marina Aznaourova, Nils Schmerer, Bernd Schmeck, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 59
Antisense Oligonucleotide-Based Therapy of Viral Infections
Woan‐Yuh Tarn, Yun Cheng, Shih-Han Ko, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2015-2015
Open Access | Times Cited: 42
Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches
Ricardo Oliveira, Eva Pinho, Ana Luísa Sousa, et al.
Trends in biotechnology (2021) Vol. 40, Iss. 5, pp. 549-563
Closed Access | Times Cited: 41
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
Life Sciences (2022) Vol. 305, pp. 120761-120761
Open Access | Times Cited: 37
Genetic therapeutic advancements for Dravet Syndrome
Ellie Chilcott, Juan Antinao Díaz, Cori Bertram, et al.
Epilepsy & Behavior (2022) Vol. 132, pp. 108741-108741
Open Access | Times Cited: 36
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
Phuc Tran, Tsigereda Weldemichael, Zhichao Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 342-342
Open Access | Times Cited: 30
Clinical Pharmacokinetics of Approved RNA Therapeutics
Seong Jun Jo, Soon Uk Chae, Chae Bin Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 746-746
Open Access | Times Cited: 21
Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO
Umme Sabrina Haque, Melissa Kohut, Toshifumi Yokota
Current Research in Toxicology (2024) Vol. 7, pp. 100182-100182
Open Access | Times Cited: 7
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
Angela Sang, S. Zhuo, Adara Bochanis, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 511-526
Closed Access | Times Cited: 6
Hepatitis E Virus Drug Development
Volker Kinast, Thomas Burkard, Daniel Tödt, et al.
Viruses (2019) Vol. 11, Iss. 6, pp. 485-485
Open Access | Times Cited: 48
Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Issa Sadeghian, Reza Heidari, Sara Sadeghian, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 169, pp. 106094-106094
Open Access | Times Cited: 38
The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
Miklós Bege, Anikó Borbás
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 909-909
Open Access | Times Cited: 27
Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot
Harry Wilton-Clark, Toshifumi Yokota
Genes (2022) Vol. 13, Iss. 2, pp. 257-257
Open Access | Times Cited: 24
Nucleic acid nanostructures for in vivo applications: The influence of morphology on biological fate
Nicole I. Langlois, Y. Kristine, Heather A. Clark
Applied Physics Reviews (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Therapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamics
Farkhad Maksudov, Evgenii Kliuchnikov, Daniel Pierson, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 631-647
Open Access | Times Cited: 14
Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment
Anabel Álvarez, Deborah Maguire, Ruairí P. Brannigan
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 435-463
Open Access
Page 1 - Next Page

Scroll to top